You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

 

Online download statistics by month:

Online download statistics by month: January 2020 to June 2025

AbstractFullPdf
Jan 2020770
Feb 202024240
Mar 202033333
Apr 202029297
May 202025258
Jun 202024247
Jul 202016166
Aug 2020303032
Sep 2020303030
Oct 2020232321
Nov 2020212118
Dec 2020282823
Jan 2021323227
Feb 2021424234
Mar 2021242419
Apr 2021232311
May 2021282823
Jun 2021424232
Jul 2021252515
Aug 2021303019
Sep 2021212116
Oct 2021525244
Nov 2021181821
Dec 2021282811
Jan 2022353620
Feb 2022343419
Mar 2022212110
Apr 2022344224
May 2022324338
Jun 2022293425
Jul 2022344122
Aug 2022282815
Sep 2022242424
Oct 2022181915
Nov 2022333418
Dec 202224259
Jan 2023404021
Feb 2023353512
Mar 2023383819
Apr 2023141410
May 202327276
Jun 202317174
Jul 2023212111
Aug 2023383825
Sep 202318199
Oct 2023303011
Nov 2023292913
Dec 2023535313
Jan 2024404021
Feb 202420209
Mar 2024313181
Apr 2024212230
May 2024202014
Jun 2024222213
Jul 2024404121
Aug 202414148
Sep 2024222214
Oct 2024212119
Nov 2024373825
Dec 2024353614
Jan 2025717123
Feb 2025919118
Mar 2025444421
Apr 2025383811
May 2025333316
Jun 2025262612
Total198720271190